TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial
Brief Summary: Improving adherence to inhaled corticosteroids (ICS) medication in urban minority pediatric populations is a clinical and population health priority. Financial incentives have been shown as a compelling method to engage a high-risk asthma population in regular ICS use, but whether and how adherence can be maintained and lead to sustained high adherence trajectories is unknown.


Options:
A: Arm Label: Active Feedback; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Feedback | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Active Feedback | Intervention Type: BEHAVIORAL; Name: Active Feedback; Assigned to Arm(s): Active Feedback, Control
B: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Other: ASTHMAXcel App | Arm Label: Usual Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: ASTHMAXcel App; Assigned to Arm(s): Intervention Arm
C: Arm Label: Arm 1: Incentives, plus reminders & feedback (IRF); Type: EXPERIMENTAL; Interventions: Other: Nominal Financial Incentives, Other: Daily Adherence Reminders/Adherence Performance Feedback | Arm Label: Arm 2: Reminders & feedback ONLY; Type: ACTIVE_COMPARATOR; Interventions: Other: Daily Adherence Reminders/Adherence Performance Feedback | Arm Label: Arm 3 (Control); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nominal Financial Incentives; Assigned to Arm(s): Arm 1: Incentives, plus reminders & feedback (IRF) | Intervention Type: OTHER; Name: Daily Adherence Reminders/Adherence Performance Feedback; Assigned to Arm(s): Arm 1: Incentives, plus reminders & feedback (IRF), Arm 2: Reminders & feedback ONLY
D: Arm Label: Feedback and alarms; Type: EXPERIMENTAL; Interventions: Device: Activated Smartinhaler or Smartturbo, Other: Feedback of adherence data | Arm Label: No feedback or alarms; Type: ACTIVE_COMPARATOR; Interventions: Device: Deactivated Smartinhaler or Smartturbo | Intervention Type: DEVICE; Name: Activated Smartinhaler or Smartturbo; Assigned to Arm(s): Feedback and alarms | Intervention Type: OTHER; Name: Feedback of adherence data; Assigned to Arm(s): Feedback and alarms | Intervention Type: DEVICE; Name: Deactivated Smartinhaler or Smartturbo; Assigned to Arm(s): No feedback or alarms

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults
Brief Summary: The SMART 2.0 study is a 24-month trial designed to evaluate the impact of the intervention with technology and personal health coaching or with technology alone on objectively measured weight among overweight young adults in a university setting over 24 months compared to a control group. The investigators hypothesize that both interventions will significantly improve weight compared to the control group, and the group receiving personal health coaching will experience the greatest improvement.


Options:
A: Arm Label: Treatment One; Type: EXPERIMENTAL; Interventions: Behavioral: SMART 2.0 | Arm Label: Treatment Two; Type: EXPERIMENTAL; Interventions: Behavioral: SMART 2.0 | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMART 2.0; Assigned to Arm(s): Treatment One, Treatment Two
B: Arm Label: Experimental: Group Sessions; Type: EXPERIMENTAL; Interventions: Behavioral: Group Sessions, Behavioral: Feedback, Behavioral: Self-monitoring | Arm Label: Active Comparator: Self-Monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring | Arm Label: Experimental: Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback, Behavioral: Self-monitoring | Intervention Type: BEHAVIORAL; Name: Group Sessions; Assigned to Arm(s): Experimental: Group Sessions | Intervention Type: BEHAVIORAL; Name: Feedback; Assigned to Arm(s): Experimental: Feedback, Experimental: Group Sessions | Intervention Type: BEHAVIORAL; Name: Self-monitoring; Assigned to Arm(s): Active Comparator: Self-Monitoring, Experimental: Feedback, Experimental: Group Sessions
C: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Use of PDA + support to reduce weight and pain | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: MOVE! level 2 group weight loss counseling | Intervention Type: BEHAVIORAL; Name: Use of PDA + support to reduce weight and pain; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: MOVE! level 2 group weight loss counseling; Assigned to Arm(s): Arm 2
D: Arm Label: Obesity Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Obesity Prevention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Obesity Prevention; Assigned to Arm(s): Obesity Prevention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Do Dual Mobility Cups Prevent Dislocation After Total Hip Arthroplasty Performed Due to Femoral Neck Fracture? a Registry-based, Pragmatic, Randomized Controlled Trial Comparing Dual Mobility with Standard Cups
Brief Summary: Our aim is to develop a strategy that reduces the risk of dislocations after total hip arthroplasty surgery performed due to femoral neck fracture. We therefore perform a register-nested, pragmatic, randomized controlled trial to investigate the safety and efficacy of dual mobility cups that were designed to minimize the risk of dislocation in the large and fragile group of elderly patients with femoral neck fractures.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Device: Total hip arthroplasty | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Hemi-arthroplasty | Intervention Type: DEVICE; Name: Total hip arthroplasty; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: Hemi-arthroplasty; Assigned to Arm(s): 2
B: Arm Label: Cemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cemented femoral stem | Arm Label: Uncemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Uncemented femoral stem; Assigned to Arm(s): Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Cemented femoral stem; Assigned to Arm(s): Cemented femoral stem
C: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Device: Cemented hemiarthroplasty | Arm Label: Treatment group; Type: ACTIVE_COMPARATOR; Interventions: Device: Cemented total hip arthroplasty | Intervention Type: DEVICE; Name: Cemented total hip arthroplasty; Assigned to Arm(s): Treatment group | Intervention Type: DEVICE; Name: Cemented hemiarthroplasty; Assigned to Arm(s): Control group
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Dual mobility cup | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard cup | Intervention Type: DEVICE; Name: Dual mobility cup; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: Standard cup; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Do Dual Mobility Cups Prevent Dislocation After Total Hip Arthroplasty Performed Due to Femoral Neck Fracture? a Registry-based, Pragmatic, Randomized Controlled Trial Comparing Dual Mobility with Standard Cups
Brief Summary: Our aim is to develop a strategy that reduces the risk of dislocations after total hip arthroplasty surgery performed due to femoral neck fracture. We therefore perform a register-nested, pragmatic, randomized controlled trial to investigate the safety and efficacy of dual mobility cups that were designed to minimize the risk of dislocation in the large and fragile group of elderly patients with femoral neck fractures.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Device: Dual mobility cup | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard cup | Intervention Type: DEVICE; Name: Dual mobility cup; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: Standard cup; Assigned to Arm(s): Control
B: Arm Label: Gamma nail, fracture stabilization, better walking; Type: ACTIVE_COMPARATOR; Interventions: Device: gamma nail stryker | Intervention Type: DEVICE; Name: gamma nail stryker; Assigned to Arm(s): Gamma nail, fracture stabilization, better walking
C: Arm Label: Conservative Treatment for Impacted Femoral Neck Fracture; Type: EXPERIMENTAL; Interventions: Procedure: Surgical Treatment for Impacted Femoral Neck Fracture | Intervention Type: PROCEDURE; Name: Surgical Treatment for Impacted Femoral Neck Fracture; Assigned to Arm(s): Conservative Treatment for Impacted Femoral Neck Fracture
D: Arm Label: Cemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cemented femoral stem | Arm Label: Uncemented femoral stem; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Uncemented femoral stem; Assigned to Arm(s): Uncemented femoral stem | Intervention Type: PROCEDURE; Name: Cemented femoral stem; Assigned to Arm(s): Cemented femoral stem

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of PUSH Notifications From a Mobile App for Improving the Body Composition of Overweight or Obese Women. Protocol of a Three-armed Clinical Assay
Brief Summary: A clinical three-armed assay has been established to permit an evaluation of the effectiveness of implementing PUSH notifications in the actions orientated towards improving body composition through the establishment of dietary patterns and an increase in physical activity.


Options:
A: Arm Label: Control: Lifestyle counseling; Type: ACTIVE_COMPARATOR; Interventions: Other: Control: Lifestyle counseling | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Intervention group, Other: Control: Lifestyle counseling | Intervention Type: OTHER; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Control: Lifestyle counseling; Assigned to Arm(s): Control: Lifestyle counseling, Intervention group
B: Arm Label: Experimental: Group Sessions; Type: EXPERIMENTAL; Interventions: Behavioral: Group Sessions, Behavioral: Feedback, Behavioral: Self-monitoring | Arm Label: Active Comparator: Self-Monitoring; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring | Arm Label: Experimental: Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback, Behavioral: Self-monitoring | Intervention Type: BEHAVIORAL; Name: Group Sessions; Assigned to Arm(s): Experimental: Group Sessions | Intervention Type: BEHAVIORAL; Name: Feedback; Assigned to Arm(s): Experimental: Feedback, Experimental: Group Sessions | Intervention Type: BEHAVIORAL; Name: Self-monitoring; Assigned to Arm(s): Active Comparator: Self-Monitoring, Experimental: Feedback, Experimental: Group Sessions
C: Arm Label: HABIT Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: HABIT | Arm Label: TRE Group; Type: EXPERIMENTAL; Interventions: Behavioral: TRE | Intervention Type: BEHAVIORAL; Name: TRE; Assigned to Arm(s): TRE Group | Intervention Type: BEHAVIORAL; Name: HABIT; Assigned to Arm(s): HABIT Group
D: Arm Label: Control Group (CG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group (CG) | Arm Label: Moderate physical activity group (MPA); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Moderate physical activity group (MPA) | Arm Label: Intense physical activity group (IPA); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intense physical activity group (IPA) | Intervention Type: BEHAVIORAL; Name: Control Group (CG); Assigned to Arm(s): Control Group (CG) | Intervention Type: BEHAVIORAL; Name: Moderate physical activity group (MPA); Assigned to Arm(s): Moderate physical activity group (MPA) | Intervention Type: BEHAVIORAL; Name: Intense physical activity group (IPA); Assigned to Arm(s): Intense physical activity group (IPA)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
Brief Summary: The purpose of this study is to evaluate the efficacy, safety, pharmacodynamic (PD) and pharmacokinetic (PK) effect of VX-561.


Options:
A: Arm Label: Ivacaftor; Type: ACTIVE_COMPARATOR; Interventions: Drug: IVA, Drug: Placebo | Arm Label: VX-561: 25 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-561, Drug: Placebo | Arm Label: VX-561: 50 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-561, Drug: Placebo | Arm Label: VX-561: 150 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-561, Drug: Placebo | Arm Label: VX-561: 250 mg; Type: EXPERIMENTAL; Interventions: Drug: VX-561, Drug: Placebo | Intervention Type: DRUG; Name: VX-561; Assigned to Arm(s): VX-561: 150 mg, VX-561: 25 mg, VX-561: 250 mg, VX-561: 50 mg | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): Ivacaftor | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): VX-561: 150 mg, VX-561: 25 mg, VX-561: 250 mg, VX-561: 50 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Ivacaftor
B: Arm Label: ELX/TEZ/IVA; Type: EXPERIMENTAL; Interventions: Drug: ELX/TEZ/IVA, Drug: IVA | Intervention Type: DRUG; Name: ELX/TEZ/IVA; Assigned to Arm(s): ELX/TEZ/IVA | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): ELX/TEZ/IVA
C: Arm Label: Ataluren; Type: EXPERIMENTAL; Interventions: Drug: Ataluren | Intervention Type: DRUG; Name: Ataluren; Assigned to Arm(s): Ataluren
D: Arm Label: LUM/IVA; Type: EXPERIMENTAL; Interventions: Drug: VX-809, Drug: VX-770 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: VX-809; Assigned to Arm(s): LUM/IVA | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: VX-770; Assigned to Arm(s): LUM/IVA

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects Aged 18 Years and Older With Cystic Fibrosis
Brief Summary: The purpose of this study is to evaluate the safety, tolerability and efficacy of VX-121 combination therapy in subjects with cystic fibrosis (CF).


Options:
A: Arm Label: ELX/TEZ/IVA; Type: EXPERIMENTAL; Interventions: Drug: ELX/TEZ/IVA, Drug: IVA | Intervention Type: DRUG; Name: ELX/TEZ/IVA; Assigned to Arm(s): ELX/TEZ/IVA | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): ELX/TEZ/IVA
B: Arm Label: Part 1: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Part 1: VX-121/TEZ/VX-561 TC - Low Dose; Type: EXPERIMENTAL; Interventions: Drug: VX-121, Drug: TEZ, Drug: VX-561 | Arm Label: Part 1: VX-121/TEZ/VX-561 TC - Medium Dose; Type: EXPERIMENTAL; Interventions: Drug: VX-121, Drug: TEZ, Drug: VX-561 | Arm Label: Part 1: VX-121/TEZ/VX-561 TC - High Dose; Type: EXPERIMENTAL; Interventions: Drug: VX-121, Drug: TEZ, Drug: VX-561 | Arm Label: Part 2: TEZ/IVA; Type: ACTIVE_COMPARATOR; Interventions: Drug: TEZ/IVA, Drug: IVA | Arm Label: Part 2: VX-121/TEZ/VX-561 TC - High Dose; Type: EXPERIMENTAL; Interventions: Drug: VX-121, Drug: TEZ, Drug: VX-561 | Intervention Type: DRUG; Name: VX-121; Assigned to Arm(s): Part 1: VX-121/TEZ/VX-561 TC - High Dose, Part 1: VX-121/TEZ/VX-561 TC - Low Dose, Part 1: VX-121/TEZ/VX-561 TC - Medium Dose, Part 2: VX-121/TEZ/VX-561 TC - High Dose | Intervention Type: DRUG; Name: TEZ; Assigned to Arm(s): Part 1: VX-121/TEZ/VX-561 TC - High Dose, Part 1: VX-121/TEZ/VX-561 TC - Low Dose, Part 1: VX-121/TEZ/VX-561 TC - Medium Dose, Part 2: VX-121/TEZ/VX-561 TC - High Dose | Intervention Type: DRUG; Name: VX-561; Assigned to Arm(s): Part 1: VX-121/TEZ/VX-561 TC - High Dose, Part 1: VX-121/TEZ/VX-561 TC - Low Dose, Part 1: VX-121/TEZ/VX-561 TC - Medium Dose, Part 2: VX-121/TEZ/VX-561 TC - High Dose | Intervention Type: DRUG; Name: TEZ/IVA; Assigned to Arm(s): Part 2: TEZ/IVA | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): Part 2: TEZ/IVA | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Part 1: Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 150 mg Ivacaftor q12h; Type: EXPERIMENTAL; Interventions: Drug: Ivacaftor | Intervention Type: DRUG; Name: Ivacaftor; Assigned to Arm(s): 150 mg Ivacaftor q12h | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Part A: ELX/TEZ/IVA; Type: EXPERIMENTAL; Interventions: Drug: ELX/TEZ/IVA, Drug: IVA | Arm Label: Part B: ELX/TEZ/IVA; Type: EXPERIMENTAL; Interventions: Drug: ELX/TEZ/IVA, Drug: IVA | Intervention Type: DRUG; Name: ELX/TEZ/IVA; Assigned to Arm(s): Part A: ELX/TEZ/IVA, Part B: ELX/TEZ/IVA | Intervention Type: DRUG; Name: IVA; Assigned to Arm(s): Part A: ELX/TEZ/IVA, Part B: ELX/TEZ/IVA

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Robotic Neurorehabilitation Plus Virtual Reality on Attention Process and Executive Functions in Patients With Chronic Stroke: a Randomized Controlled Trial
Brief Summary: Stroke can be classified as ischemic, i.e. due to the lack of blood flow, and haemorrhagic, caused by bleeding. Stroke results in focal signs and symptoms, with a devastating impact on a patient and his family. Although robotic rehabilitation is very useful in improving motor function, there is no a clear evidence on its role in improving cognitive abilities, which are often compromised in stroke patients.

To this end, the investigators designed a randomized controlled experimental study on stroke patients, with the aim of evaluating the effects of robotic neurorehabilitation using Lokomat with and without virtual reality on cognitive functioning in stroke patients, compared to traditional therapy.


Options:
A: Arm Label: CO-OP; Type: EXPERIMENTAL; Interventions: Behavioral: CO-OP | Arm Label: Attention Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: CO-OP; Assigned to Arm(s): CO-OP | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention Control
B: Arm Label: Guided Training; Type: EXPERIMENTAL; Interventions: Behavioral: Guided Training | Arm Label: Directed Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Directed Training | Intervention Type: BEHAVIORAL; Name: Guided Training; Assigned to Arm(s): Guided Training | Intervention Type: BEHAVIORAL; Name: Directed Training; Assigned to Arm(s): Directed Training
C: Arm Label: Robotic Treatment plus VR; Type: EXPERIMENTAL; Interventions: Device: Robotic Treatment plus VR | Arm Label: Robotic treatment without VR; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotic Treatment plus VR | Arm Label: Conventional treatment; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotic Treatment plus VR | Intervention Type: DEVICE; Name: Robotic Treatment plus VR; Assigned to Arm(s): Conventional treatment, Robotic Treatment plus VR, Robotic treatment without VR
D: Arm Label: Self-Management group-intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Self-Management group-intervention | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Care | Intervention Type: BEHAVIORAL; Name: Self-Management group-intervention; Assigned to Arm(s): Self-Management group-intervention | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Nurse-Led Intervention Programme on Compassion Fatigue, Burnout, Compassion
Brief Summary: Nurses are at risk in terms of burnout and empathic fatigue. Therefore, efforts to protect the mental health of nurses are very important. It is stated that the studies conducted are mostly descriptive and not interventional.

In addition, the evidence levels of interventional studies are low.


Options:
A: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
B: Arm Label: Continuous intensivist staffing model; Type: N/A; Interventions: Other: Alternative Intensivist staffing models. | Arm Label: Discontinuous intensivist staffing model; Type: N/A; Interventions: Other: Alternative Intensivist staffing models. | Intervention Type: OTHER; Name: Alternative Intensivist staffing models.; Assigned to Arm(s): Continuous intensivist staffing model, Discontinuous intensivist staffing model
C: Arm Label: Nurse led intervention group; Type: EXPERIMENTAL; Interventions: Other: Nurse led intervention group | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nurse led intervention group; Assigned to Arm(s): Nurse led intervention group
D: Arm Label: Mental Training for Surgeons; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Based Stress Reduction - modified | Arm Label: The Mind of a Surgeon; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active listening and reading | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction - modified; Assigned to Arm(s): Mental Training for Surgeons | Intervention Type: BEHAVIORAL; Name: Active listening and reading; Assigned to Arm(s): The Mind of a Surgeon

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Nurse-Led Intervention Programme on Compassion Fatigue, Burnout, Compassion
Brief Summary: Nurses are at risk in terms of burnout and empathic fatigue. Therefore, efforts to protect the mental health of nurses are very important. It is stated that the studies conducted are mostly descriptive and not interventional.

In addition, the evidence levels of interventional studies are low.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: ACTr (Acceptance and Commitment Training) | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACTr (Acceptance and Commitment Training); Assigned to Arm(s): Intervention Group
B: Arm Label: Mobile Video Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Stress management counseling | Arm Label: Offline Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stress management counseling | Arm Label: Selfcare; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stress management counseling; Assigned to Arm(s): Mobile Video Counseling, Offline Counseling
C: Arm Label: Nurse led intervention group; Type: EXPERIMENTAL; Interventions: Other: Nurse led intervention group | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nurse led intervention group; Assigned to Arm(s): Nurse led intervention group
D: Arm Label: Mindful Awareness Practices (MAPs); Type: EXPERIMENTAL; Interventions: Behavioral: Mindful Awareness Practices (MAPs) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindful Awareness Practices (MAPs); Assigned to Arm(s): Mindful Awareness Practices (MAPs)

Answer: C